Cell & Gene Therapy Europe
09/20/2017 - 09/21/2017
Dr. Nicole Faust, Chief Scientific Officer at CEVEC, will be a panelist and presenter during the following sessions:
- Panelist: „Upscaling and optimising viral vector production platforms to meet future ATMP industry demand: Part 1 – AAV“ – Track 3 on September 20 at 12:30 p.m.
- Presenter: “CAP-GT: a scalable production platform for lentiviral and AAV gene therapy vectors” – Track 3 of the ‘Vector business & innovation‘ session on September 20 at 2:35 p.m.
Visit CEVEC at Booth # 18.
13th PEACe Conference
09/24/2017 - 09/28/2017
Listen to the talk of Dr. Nikola Strempel, Head Cell Line Development at CEVEC:
„CAP-Go.2 cell line: Improved O-glycosylation for significantly prolonged plasma half-life of human recombinant C1 Inhibitor“
on Wednesday, September 27 at 09:30 a.m.